X0508 4 2025-11-12 false 0001050446 Strategy Inc MSTR 0001663488 Shao Wei-Ming C/O STRATEGY INC 1850 TOWERS CRESCENT PLAZA TYSONS CORNER VA 22182 false true false false EVP & General Counsel true Class A Common Stock 2025-11-12 4 M false 20000 40.46 A 32726 D Class A Common Stock 2025-11-12 4 M false 5334 69.123 A 38060 D Class A Common Stock 2025-11-12 4 S false 309 220.619 D 37751 D Class A Common Stock 2025-11-12 4 S false 511 221.90 D 37240 D Class A Common Stock 2025-11-12 4 S false 629 222.922 D 36611 D Class A Common Stock 2025-11-12 4 S false 727 224.064 D 35884 D Class A Common Stock 2025-11-12 4 S false 853 224.769 D 35031 D Class A Common Stock 2025-11-12 4 S false 342 225.999 D 34689 D Class A Common Stock 2025-11-12 4 S false 455 227.024 D 34234 D Class A Common Stock 2025-11-12 4 S false 111 227.888 D 34123 D Class A Common Stock 2025-11-12 4 S false 48 229.203 D 34075 D Class A Common Stock 2025-11-12 4 S false 198 230.439 D 33877 D Class A Common Stock 2025-11-12 4 S false 187 231.702 D 33690 D Class A Common Stock 2025-11-12 4 S false 348 232.964 D 33342 D Class A Common Stock 2025-11-12 4 S false 490 233.761 D 32852 D Class A Common Stock 2025-11-12 4 S false 126 234.431 D 32726 D Class A Common Stock 2025-11-13 4 M false 2600 69.123 A 35326 D Class A Common Stock 2025-11-13 4 S false 2600 223.667 D 32726 D Series A Perpetual Strife Preferred Stock 500 D Series A Perpetual Stretch Preferred Stock 15000 D Series A Perpetual Stride Preferred Stock 3527 D Employee Stock Option (Right to buy) 40.46 2025-11-12 4 M false 20000 0 D 2032-02-17 Class A Common Stock 20000 79100 D Employee Stock Option (Right to buy) 69.123 2025-11-12 4 M false 5334 0 D 2031-02-23 Class A Common Stock 5334 183998 D Employee Stock Option (Right to buy) 69.123 2025-11-13 4 M false 2600 0 D 2031-02-23 Class A Common Stock 2600 181398 D The transactions reported were effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on July 11, 2025. As previously disclosed in Strategy Inc's ("Strategy") Current Report on Form 8-K filed with the Securities and Exchange Commission ("SEC") on July 1, 2025, the reporting person informed the issuer of his intention to retire effective December 31, 2025. The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $220.235 to $221.115, inclusive. The reporting person undertakes to provide to Strategy, any security holder of Strategy, or the staff of the SEC, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote. The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $221.37 to $222.240, inclusive. The reporting person undertakes to provide to Strategy, any security holder of Strategy, or the staff of the SEC, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote. The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $222.430 to $223.426, inclusive. The reporting person undertakes to provide to Strategy, any security holder of Strategy, or the staff of the SEC, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote. The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $223.446 to $224.415, inclusive. The reporting person undertakes to provide to Strategy, any security holder of Strategy, or the staff of the SEC, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote. The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $224.45 to $225.448, inclusive. The reporting person undertakes to provide to Strategy, any security holder of Strategy, or the staff of the SEC, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote. The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $225.505 to $226.460, inclusive. The reporting person undertakes to provide to Strategy, any security holder of Strategy, or the staff of the SEC, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote. The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $226.56 to $227.50, inclusive. The reporting person undertakes to provide to Strategy, any security holder of Strategy, or the staff of the SEC, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote. The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $227.665 to $228.03, inclusive. The reporting person undertakes to provide to Strategy, any security holder of Strategy, or the staff of the SEC, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote. The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $228.81 to $229.77, inclusive. The reporting person undertakes to provide to Strategy, any security holder of Strategy, or the staff of the SEC, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote. The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $230.02 to $231.00, inclusive. The reporting person undertakes to provide to Strategy, any security holder of Strategy, or the staff of the SEC, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote. The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $231.27 to $232.05, inclusive. The reporting person undertakes to provide to Strategy, any security holder of Strategy, or the staff of the SEC, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote. The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $232.27 to $233.26, inclusive. The reporting person undertakes to provide to Strategy, any security holder of Strategy, or the staff of the SEC, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote. The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $233.32 to $234.27, inclusive. The reporting person undertakes to provide to Strategy, any security holder of Strategy, or the staff of the SEC, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote. The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $234.34 to $234.80, inclusive. The reporting person undertakes to provide to Strategy, any security holder of Strategy, or the staff of the SEC, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote. The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $223.10 to $224.04, inclusive. The reporting person undertakes to provide to Strategy, any security holder of Strategy, or the staff of the SEC, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote. The 20,000 shares exercised on November 12, 2025 pursuant to this option vested on February 17, 2025. Of the remaining 79,100 shares subject to this option, 29,100 shares vested on February 17, 2025 and 50,000 shares are scheduled to vest on February 17, 2026. The 5,334 shares exercised on November 12, 2025 pursuant to this option vested on February 23, 2022. Of the remaining 183,998 shares subject to this option, 33,998 shares vested on February 23, 2022, 50,000 shares vested on February 23, 2023, 50,000 shares vested on February 23, 2024 and 50,000 shares vested on February 23, 2025. The 2,600 shares exercised on November 13, 2025 pursuant to this option vested on February 23, 2022. Of the remaining 181,398 shares subject to this option, 31,398 shares vested on February 23, 2022, 50,000 shares vested on February 23, 2023, 50,000 shares vested on February 23, 2024 and 50,000 shares vested on February 23, 2025. /s/ Allein Sabel, Attorney-in-Fact 2025-11-14